{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:51:02Z","timestamp":1782791462283,"version":"3.54.5"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"vor","delay-in-days":293,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Applied"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.nsa.2023.102438","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T19:46:23Z","timestamp":1698090383000},"page":"102438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cerebrospinal fluid ubiquitin as a biomarker for neurodegenerative diseases: A systematic review"],"prefix":"10.1016","volume":"2","author":[{"given":"Emily G.","family":"Vardheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3559-1923","authenticated-orcid":false,"given":"Anders","family":"Toft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen G.","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5461-162X","authenticated-orcid":false,"given":"Anja H.","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nsa.2023.102438_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040497","article-title":"CSF ubiquitin levels are higher in alzheimer's disease than in frontotemporal dementia and reflect the molecular subtype in prion disease","volume":"10","author":"Abu-Rumeileh","year":"2020","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.nsa.2023.102438_bib3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0166-2236(98)01276-4","article-title":"Ubiquitin, cellular inclusions and their role in neurodegeneration","volume":"21","author":"Alves-Rodrigues","year":"1998","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib4","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nsa.2023.102438_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev-biochem-062917-011931","article-title":"Structure and function of the 26S proteasome","volume":"87","author":"Bard","year":"2018","journal-title":"Annu. Rev. Biochem."},{"issue":"9","key":"10.1016\/j.nsa.2023.102438_bib6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/01.wnl.0000256043.50901.e3","article-title":"Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker","volume":"68","author":"Bateman","year":"2007","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nsa.2023.102438_bib7","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1039\/C8SC03394C","article-title":"Ubiquitin binds the amyloid \u03b2 peptide and interferes with its clearance pathways","volume":"10","author":"Bellia","year":"2019","journal-title":"Chem. Sci."},{"issue":"5521","key":"10.1016\/j.nsa.2023.102438_bib8","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","article-title":"Impairment of the ubiquitin-proteasome system by protein aggregation","volume":"292","author":"Bence","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nsa.2023.102438_bib9","article-title":"Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid","volume":"2010","author":"Bjerke","year":"2010","journal-title":"Int. J. Alzheimer's Dis."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1041610294001584","article-title":"Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia","volume":"6","author":"Blennow","year":"1994","journal-title":"Int. Psychogeriatr."},{"issue":"9","key":"10.1016\/j.nsa.2023.102438_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd.2018.109","article-title":"Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing","volume":"17","author":"Boland","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.nsa.2023.102438_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3233\/JAD-2011-101959","article-title":"Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease","volume":"25","author":"Chalbot","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nsa.2023.102438_bib13","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1038\/emm.2014.117","article-title":"Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies","volume":"47","author":"Ciechanover","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"10.1016\/j.nsa.2023.102438_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.parkreldis.2010.06.011","article-title":"Proteomic profiling of cerebrospinal fluid in parkinsonian disorders","volume":"16","author":"Constantinescu","year":"2010","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.nsa.2023.102438_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.17145\/jab.16.015","article-title":"Can LC and LC-MS ever replace immunoassays?","author":"Cross","year":"2016","journal-title":"Journal of Applied Bioanalysis"},{"issue":"70","key":"10.1016\/j.nsa.2023.102438_bib16","article-title":"The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution","volume":"7","author":"Dantuma","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.nsa.2023.102438_bib17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00001756-200204160-00015","article-title":"Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients","volume":"13","author":"Davidsson","year":"2002","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.nsa.2023.102438_bib18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/acel.12359","article-title":"The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration","volume":"14","author":"Deger","year":"2015","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.nsa.2023.102438_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2217\/bmm.12.46","article-title":"Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update","volume":"6","author":"del Campo","year":"2012","journal-title":"Biomarkers Med."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.nsa.2023.102438_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pneurobio.2004.10.001","article-title":"Protein quality control in Alzheimer's disease by the ubiquitin proteasome system","volume":"74","author":"de Vrij","year":"2004","journal-title":"Prog Neurobiol"},{"issue":"7","key":"10.1016\/j.nsa.2023.102438_bib22","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"11","key":"10.1016\/j.nsa.2023.102438_bib23","doi-asserted-by":"crossref","first-page":"101700","DOI":"10.1016\/j.isci.2020.101700","article-title":"Ubiquitin homeostasis is disrupted in TDP-43 and FUS cell models of ALS","volume":"23","author":"Farrawell","year":"2020","journal-title":"iScience"},{"issue":"8","key":"10.1016\/j.nsa.2023.102438_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nm.3617","article-title":"Huntington's disease is a four-repeat tauopathy with tau nuclear rods","volume":"20","author":"Fern\u00e1ndez-Nogales","year":"2014","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.nsa.2023.102438_bib25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.nsa.2023.102438_bib26","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00005072-198811000-00008","article-title":"Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles","volume":"47","author":"Galloway","year":"1988","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1406","key":"10.1016\/j.nsa.2023.102438_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1098\/rstb.2000.0767","article-title":"From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases","volume":"356","author":"Goedert","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"5","key":"10.1016\/j.nsa.2023.102438_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00401-010-0679-9","article-title":"Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease","volume":"119","author":"Gouras","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nsa.2023.102438_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13024-015-0059-y","article-title":"Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay","volume":"10","author":"Heywood","year":"2015","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.nsa.2023.102438_bib30","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00401-009-0593-1","article-title":"Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene","volume":"118","author":"Holm","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.nsa.2023.102438_bib31","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ana.20639","article-title":"Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers","volume":"58","author":"Iqbal","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nsa.2023.102438_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuint.2019.04.015","article-title":"Sampling issues of cerebrospinal fluid and plasma monoamines: investigation of the circadian rhythm and rostrocaudal concentration gradient","volume":"128","author":"Janssens","year":"2019","journal-title":"Neurochem. Int."},{"issue":"7465","key":"10.1016\/j.nsa.2023.102438_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"issue":"32","key":"10.1016\/j.nsa.2023.102438_bib34","doi-asserted-by":"crossref","first-page":"19385","DOI":"10.1074\/jbc.271.32.19385","article-title":"Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme","volume":"271","author":"Kalchman","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.nsa.2023.102438_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neulet.2010.06.075","article-title":"Cerebrospinal fluid profile of amyloid \u03b242 (A\u03b242), hTau and ubiquitin in North Indian Alzheimer's disease patients","volume":"487","author":"Kandimalla","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.nsa.2023.102438_bib36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2174\/1567205011666140331161027","article-title":"CSF ubiquitin as a specific biomarker in Alzheimer's disease","volume":"11","author":"Kandimalla","year":"2014","journal-title":"Curr. Alzheimer Res."},{"issue":"10","key":"10.1016\/j.nsa.2023.102438_bib37","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jamaneurol.2020.1741","article-title":"Prevalence and clinical phenotype of quadruple misfolded proteins in older adults","volume":"77","author":"Karanth","year":"2020","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.nsa.2023.102438_bib38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of Synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.nsa.2023.102438_bib40","first-page":"CD010945","article-title":"Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting","volume":"2","author":"Kokkinou","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(94)91757-4","article-title":"Alzheimer disease: correlation of cerebro-spinal fluid and brain ubiquitin levels","volume":"639","author":"Kudo","year":"1994","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.nsa.2023.102438_bib43","first-page":"963","article-title":"[An increase in cerebrospinal fluid ubiquitin in human global brain ischemia--a prognostic marker for anoxic-ischemic encephalopathy]","volume":"37","author":"Kurimura","year":"1997","journal-title":"Rinsho Shinkeigaku"},{"issue":"786353","key":"10.1016\/j.nsa.2023.102438_bib44","article-title":"Tau ubiquitination in alzheimer's disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Neurol."},{"issue":"7","key":"10.1016\/j.nsa.2023.102438_bib45","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1515\/CCLM.2011.600","article-title":"Preanalytical quality improvement: from dream to reality","volume":"49","author":"Lippi","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.nsa.2023.102438_bib46","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.nsa.2023.102438_bib48","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000169883.41245.23","article-title":"Ubiquitin immunoreactivity in cerebrospinal fluid after traumatic brain injury: clinical and experimental findings","volume":"33","author":"Majetschak","year":"2005","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.nsa.2023.102438_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1189\/jlb.0510316","article-title":"Extracellular ubiquitin: immune modulator and endogenous opponent of damage-associated molecular pattern molecules","volume":"89","author":"Majetschak","year":"2011","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0304-3940(92)90854-Z","article-title":"Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob disease","volume":"139","author":"Manaka","year":"1992","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.nsa.2023.102438_bib51","doi-asserted-by":"crossref","first-page":"190147","DOI":"10.1098\/rsob.190147","article-title":"Cellular functions and molecular mechanisms of non-lysine ubiquitination","volume":"9","author":"McClellan","year":"2019","journal-title":"Open Biol"},{"issue":"3","key":"10.1016\/j.nsa.2023.102438_bib52","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3390\/cimb45030160","article-title":"Ubiquitin is not a blood biomarker of an early cognitive decline in the polish elderly","volume":"45","author":"McFarlane","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"2","key":"10.1016\/j.nsa.2023.102438_bib53","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/17482968.2010.542002","article-title":"Neurofilament heavy subunit in cerebrospinal fluid: a biomarker of amyotrophic lateral sclerosis?","volume":"12","author":"Mendon\u00e7a","year":"2011","journal-title":"Amyotroph Lateral Scler."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00308955","article-title":"Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis","volume":"79","author":"Mizusawa","year":"1989","journal-title":"Acta Neuropathol."},{"issue":"4796","key":"10.1016\/j.nsa.2023.102438_bib55","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1126\/science.3029875","article-title":"Ubiquitin is a component of paired helical filaments in Alzheimer's disease","volume":"235","author":"Mori","year":"1987","journal-title":"Science"},{"issue":"5796","key":"10.1016\/j.nsa.2023.102438_bib56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.nsa.2023.102438_bib57","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1021\/pr5006058","article-title":"Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration","volume":"13","author":"Oeckl","year":"2014","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00401-019-02093-x","article-title":"Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis","volume":"139","author":"Oeckl","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.nsa.2023.102438_bib59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000447239","article-title":"Increased cerebrospinal fluid levels of ubiquitin carboxyl-terminal hydrolase L1 in patients with alzheimer's disease","volume":"6","author":"\u00d6hrfelt","year":"2016","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"issue":"9","key":"10.1016\/j.nsa.2023.102438_bib60","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5483\/BMBRep.2014.47.9.128","article-title":"Cellular ubiquitin pool dynamics and homeostasis","volume":"47","author":"Park","year":"2014","journal-title":"BMB Rep"},{"issue":"9","key":"10.1016\/j.nsa.2023.102438_bib61","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1073\/pnas.84.9.3033","article-title":"Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains","volume":"84","author":"Perry","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nsa.2023.102438_bib62","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.nsa.2023.102438_bib63","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cell.2011.07.030","article-title":"Autophagy and aging","volume":"146","author":"Rubinsztein","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.nsa.2023.102438_bib64","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","article-title":"Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities","volume":"28","author":"Schmidt","year":"2021","journal-title":"Cell Death Differ."},{"issue":"Pt 6","key":"10.1016\/j.nsa.2023.102438_bib65","first-page":"1263","article-title":"Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species","volume":"127","author":"Scotter","year":"2014","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.nsa.2023.102438_bib66","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00415-009-5404-z","article-title":"Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration","volume":"257","author":"Seelaar","year":"2010","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.nsa.2023.102438_bib67","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jneumeth.2013.03.011","article-title":"Pre-analytical factors influencing the stability of cerebrospinal fluid proteins","volume":"215","author":"Simonsen","year":"2013","journal-title":"J. Neurosci. Methods"},{"issue":"11\u201312","key":"10.1016\/j.nsa.2023.102438_bib68","article-title":"Mass spectrometric analysis of cerebrospinal fluid ubiquitin in alzheimer's disease and parkinsonian disorders","volume":"11","author":"Sj\u00f6din","year":"2017","journal-title":"Proteonomics Clin. Appl."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-019-0533-9","article-title":"Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease","volume":"11","author":"Sj\u00f6din","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"issue":"11","key":"10.1016\/j.nsa.2023.102438_bib70","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/pmic.200900246","article-title":"Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease","volume":"10","author":"Steinacker","year":"2010","journal-title":"Proteomics"},{"issue":"4","key":"10.1016\/j.nsa.2023.102438_bib72","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/pin.12520","article-title":"Plaque formation and the intraneuronal accumulation of \u03b2-amyloid in Alzheimer's disease","volume":"67","author":"Takahashi","year":"2017","journal-title":"Pathol. Int."},{"issue":"45","key":"10.1016\/j.nsa.2023.102438_bib73","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","article-title":"Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function","volume":"278","author":"Tofaris","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib74","article-title":"Endo-lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation","volume":"15","author":"Toft","year":"2023","journal-title":"Alzheimers Dement (Amst)"},{"issue":"3","key":"10.1016\/j.nsa.2023.102438_bib75","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ajpath.2011.11.012","article-title":"Decreased proteasomal activity causes age-related phenotypes and promotes the development of metabolic abnormalities","volume":"180","author":"Tomaru","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib76","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-020-00245-6","article-title":"Beyond K48 and K63: non-canonical protein ubiquitination","volume":"26","author":"Tracz","year":"2021","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"931968","key":"10.1016\/j.nsa.2023.102438_bib77","article-title":"Functional implication of ubiquitinating and deubiquitinating mechanisms in TDP-43 proteinopathies","volume":"10","author":"Tran","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"105144","key":"10.1016\/j.nsa.2023.102438_bib78","first-page":"147","article-title":"Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis","author":"Ugbode","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.nsa.2023.102438_bib79","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/ene.12750","article-title":"Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease","volume":"22","author":"Vinther-Jensen","year":"2015","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.nsa.2023.102438_bib80","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jnc.14698","article-title":"Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions","volume":"150","author":"Walker","year":"2019","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF00310917","article-title":"Alzheimer's disease: paired helical filament immunoreactivity in cerebrospinal fluid","volume":"82","author":"Wang","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.nsa.2023.102438_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092022","article-title":"Ubiquitin, autophagy and neurodegenerative diseases","volume":"9","author":"Watanabe","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.nsa.2023.102438_bib84","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13195-021-00841-4","article-title":"A neurologist's perspective on serum neurofilament light in the memory clinic: a prospective implementation study","volume":"13","author":"Willemse","year":"2021","journal-title":"Alzheimer's Res. Ther."}],"container-title":["Neuroscience Applied"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772408523014205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772408523014205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T02:20:22Z","timestamp":1731378022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772408523014205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":80,"alternative-id":["S2772408523014205"],"URL":"https:\/\/doi.org\/10.1016\/j.nsa.2023.102438","relation":{},"ISSN":["2772-4085"],"issn-type":[{"value":"2772-4085","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid ubiquitin as a biomarker for neurodegenerative diseases: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Applied","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nsa.2023.102438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European College of Neuropsychopharmacology.","name":"copyright","label":"Copyright"}],"article-number":"102438"}}